OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility
Source: Streetwise Reports  (3/13/20)
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast. More >

Predictive Oncology Launches AI Vaccine and Drug Platform & Acquires Technology
Source: Streetwise Reports  (3/12/20)
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology. More >

Surgical Imaging Firm Reports Positive Physician Response to Bladder Cancer Visualization System
Source: Streetwise Reports  (3/11/20)
Imagin Medical announced on-going research feedback on its i/Blueâ„¢ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures. More >

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses
Source: Streetwise Reports  (3/11/20)
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. More >

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test
Source: Streetwise Reports  (3/10/20)
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. More >

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment
Source: Streetwise Reports  (3/9/20)
Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. More >

Digital Health & Telemedicine Firm Increases Doctor Onboarding Amid Coronavirus Worries
Source: Streetwise Reports  (3/9/20)
CloudMD reported it's accelerating onboarding of physicians amid rising COVID-19 concerns. The firm also advised it is on track to close a new CA$3 million brokered financing on March 11, 2020. More >

U.S.-Based Biotech 'Growing into a Giant with AI'
Source: Streetwise Reports  (3/7/20)
How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. More >

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing
Source: Streetwise Reports  (3/6/20)
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. More >

Avivagen to Be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD on March 6
Source: Streetwise Reports  (3/5/20)
Webcast will be at 12 noon ET on Friday, March 6. More >

Antibody Developer Taken Out by Gilead at 'Hefty Premium'
Source: Streetwise Reports  (3/4/20)
The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. More >

Digital Health Firm to Place Telemedicine Kiosks in Pharmacy Consult Rooms
Source: Streetwise Reports  (3/4/20)
CloudMD announced it will be installing proprietary kiosks in participating pharmacies to enable on-demand telemedicine visits with licensed physicians. More >

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data
Source: Streetwise Reports  (3/4/20)
Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. More >

Telemedicine Platform Provider for Community-Based Healthcare Adds 50,000 Medicare Members
Source: Streetwise Reports  (3/3/20)
Reliq Health Technologies reported that it has signed a contract with Blum Telehealth to provide its iUGO Care software platform to over 50,000 Medicare patients in the state of Louisiana. More >

GenMark Shares Trade 30% Higher on Yearly Earnings and Increased SARS-CoV-2 Virus Detection Test Kit Shipments
Source: Streetwise Reports  (3/3/20)
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus. More >

Digital Health Firm Scales Up Telemedicine Services as Global Coronavirus Concerns Mount
Source: Streetwise Reports  (3/2/20)
CloudMD will be scaling up its freely accessible telemedicine app that allows patients to see a doctor in real-time using either a smartphone or desktop device. More >

Health Tech Firm to Service Sizable Home Healthcare Network
Source: Streetwise Reports  (3/2/20)
Reliq Health Technologies will provide its software and call center support. More >

Karyopharm Trades Up 60% on Positive Phase 3 Multiple Myeloma Results
Source: Streetwise Reports  (3/2/20)
Karyopharm Therapeutics shares set a new 52-week high price after the company reported that its Phase 3 BOSTON trial of XPOVIO® achieved significant increases in progression-free survival in patients suffering with multiple myeloma. More >

Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration
Source: Streetwise Reports  (2/28/20)
Sangamo Therapeutics shares traded higher after the company reported Q4/19 and FY/19 earnings and advised that it signed a global collaboration agreement with Biogen to develop gene regulation therapies for Alzheimer's, Parkinson's, neuromuscular and neurological diseases. More >

Teladoc Shares Trade 20% Higher on Virtual Medicine Tailwinds and Q4 Earnings
Source: Streetwise Reports  (2/27/20)
Shares of Teladoc Health climbed to a new 52-week high price after the firm reported Q4/19 and FY/19 financial results that included a 32% year-over-year increase in revenue and a 57% increase in patient visits. More >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports  (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. More >

Mobile Health and Telemedicine Provider for Community-Based Healthcare Teams Up with US Health Data Firm
Source: Streetwise Reports  (2/26/20)
Reliq Health Technologies advised that it has been selected as remote patient monitoring and chronic care management solutions partner by U.S. health data company MaxMD. More >

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study
Source: Streetwise Reports  (2/25/20)
Shares of Moderna traded 23% higher after the company reported that it has developed and shipped an mRNA vaccine against novel coronavirus for use in a Phase 1 testing study in the U.S. More >

Two Stock-Moving Catalysts Expected in March for Biopharma
Source: Streetwise Reports  (2/25/20)
These events for Axsome Therapeutics are described in an H.C. Wainwright & Co. report. More >

NGM Biopharma Shares Rise on Positive Topline Data from Phase 2 NASH Trial
Source: Streetwise Reports  (2/24/20)
Shares of NGM Biopharmaceuticals reached a new 52-week intraday high price after the company posted positive topline data from Cohort 4 of its Phase 2 study of aldafermin in NASH Patients. More >